Frec Markets’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
Other funds holding BMRN
Frec Markets's BMRN Position: Q3 2026 in Review
Frec Markets increased its BioMarin Pharmaceuticals (BMRN) stake by 17% in Q3 2026, buying an estimated $217K and bringing the position to 24,003 shares worth $1.44M. The position accounts for 0.09% of the portfolio, ranked #242.
Frec Markets first reported a position in BMRN in Q1 2026 and has held it in 3 quarters since. 567 funds tracked by Wall St. Rank hold BMRN as of Q3 2026.
- Frec Markets held 24,003 shares of BioMarin Pharmaceuticals worth $1.44M as of Q3 2026.
- Frec Markets bought 3,448 BioMarin Pharmaceuticals shares in Q3 2026, an estimated $217K.
- BioMarin Pharmaceuticals made up 0.09% of Frec Markets's portfolio in Q3 2026, its #242 holding.
- Frec Markets first reported a position in BioMarin Pharmaceuticals in Q1 2026 and has held it in 3 quarters since.
- 567 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q3 2026.
Based on Frec Markets's 13F filing for Q3 2026, filed 16 Nov 2026.